Graft Polymer UK PLC
LSE:GPL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
G
|
Graft Polymer UK PLC
LSE:GPL
|
3.8m GBP |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
85.9B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
79.9B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
10.5T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
263.7B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
29B CHF |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.6T INR |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
25B USD |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| US |
|
Albemarle Corp
NYSE:ALB
|
22.4B USD |
Loading...
|
Market Distribution
| Min | -195 650% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 4 630.7% |
Other Profitability Ratios
Graft Polymer UK PLC
Glance View
Graft Polymer (UK) Ltd. is a holding company, which comprises polymer modification and drug delivery systems developments. The firm's primary business comprises polymer modification and drug delivery systems developments. The company develops range of products, including grafted polymer modifiers; nano-structured and crosslinking polymer alloys; and a variety of delivery vehicles for pharma and bio applications. Its products fall into the category of standard products, such as Polypropylene-based composites, Polyamide-based composites, and other composites; custom made products; and innovative products, such as GRAFTALLOY, GRAFTAKIT, GRAFTAMER TRC, and GRAFTAMER VTR. The firm provides three main types of modification solutions, including Graft/Block copolymers, Polymeric Nano-Structured Alloys and Crosslinking Master batches.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Graft Polymer UK PLC is -489.9%, which is above its 3-year median of -511.6%.
Over the last 1 years, Graft Polymer UK PLC’s Operating Margin has increased from -668.3% to -489.9%. During this period, it reached a low of -668.3% on May 30, 2023 and a high of -376.5% on Dec 31, 2023.